| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |